Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Polomar Health Services (PMHS) Cost of Revenue (2023 - 2025)

Polomar Health Services has reported Cost of Revenue over the past 3 years, most recently at $14099.0 for Q3 2025.

  • For Q3 2025, Cost of Revenue rose 20.63% year-over-year to $14099.0; the TTM value through Sep 2025 reached $3789.0, down 90.95%, while the annual FY2024 figure was $27921.0, 550.23% up from the prior year.
  • Cost of Revenue for Q3 2025 was $14099.0 at Polomar Health Services, up from $10507.0 in the prior quarter.
  • Over five years, Cost of Revenue peaked at $14099.0 in Q3 2025 and troughed at -$22177.0 in Q4 2024.
  • A 3-year average of $5882.1 and a median of $10507.0 in 2025 define the central range for Cost of Revenue.
  • On a YoY basis, Cost of Revenue climbed as much as 60.7% in 2024 and fell as far as 1097.17% in 2024.
  • Year by year, Cost of Revenue stood at $2224.0 in 2023, then crashed by 1097.17% to -$22177.0 in 2024, then surged by 163.57% to $14099.0 in 2025.
  • Business Quant data shows Cost of Revenue for PMHS at $14099.0 in Q3 2025, $10507.0 in Q2 2025, and $1360.0 in Q1 2025.